QuidelOrtho (QDEL) director granted multiple new restricted stock unit awards
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
QuidelOrtho Corp director Mary Lake Polan, Ph.D., reported grants of restricted stock units tied to her board service. On June 25, 2026, she received three awards of premium, converted, and equity grant RSUs covering 1,664, 5,547 and 15,532 units, each representing one share of common stock. Some units vest entirely on June 25, 2027, while 1,386 units vested on June 25, 2026 and additional 1,387-unit tranches will vest on September 25, 2026, December 25, 2026, and March 25, 2027. The RSUs were received in lieu of cash retainers and board-related fees under a deferred compensation program for non-employee directors, with release of vested shares following her elected deferral schedule.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
POLAN MARY LAKE PH D
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units (Equity Grant) | 15,532 | $0.00 | -- |
| Grant/Award | Restricted Stock Units (Converted) | 5,547 | $0.00 | -- |
| Grant/Award | Restricted Stock Units (Premium) | 1,664 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units (Equity Grant) — 15,532 shares (Direct, null);
Restricted Stock Units (Converted) — 5,547 shares (Direct, null);
Restricted Stock Units (Premium) — 1,664 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. The restricted stock units will vest on June 25, 2027. The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. 1,386 shares vested on June 25, 2026, 1,387 shares will vest on September 25, 2026, 1,387 shares will vest on December 25, 2026, and 1,387 shares will vest on March 25, 2027.
Key Figures
Premium RSU grant size: 1,664 units
Converted RSU grant size: 5,547 units
Equity grant RSU size: 15,532 units
+3 more
6 metrics
Premium RSU grant size
1,664 units
Restricted Stock Units (Premium) granted on June 25, 2026
Converted RSU grant size
5,547 units
Restricted Stock Units (Converted) granted on June 25, 2026
Equity grant RSU size
15,532 units
Restricted Stock Units (Equity Grant) on June 25, 2026
First vesting tranche
1,386 units
Vested on June 25, 2026
Subsequent vesting tranches
1,387 units each
Vest on Sept 25, 2026; Dec 25, 2026; Mar 25, 2027
RSU-to-share ratio
1 unit : 1 share
Each RSU represents one share of common stock
Key Terms
Restricted Stock Units, deferred compensation program, retainer and Board of Director service-related fees, vest
4 terms
Restricted Stock Units financial
"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
deferred compensation program financial
"under a deferred compensation program applicable to participating non-employee directors."
vest financial
"The restricted stock units will vest on June 25, 2027."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What did QuidelOrtho (QDEL) director Mary Lake Polan report on this Form 4?
She reported three grants of restricted stock units on June 25, 2026, covering 1,664, 5,547, and 15,532 units. Each unit represents one share of QuidelOrtho common stock and reflects compensation for her service on the company’s board of directors.
Are the QuidelOrtho (QDEL) restricted stock units immediately vested?
No, the restricted stock units vest over time. One set vests on June 25, 2027, while 1,386 units vested June 25, 2026 and three additional tranches of 1,387 units each will vest on specified dates through March 25, 2027.
How many QuidelOrtho (QDEL) RSUs did Mary Lake Polan hold after these transactions?
After the transactions, she held 1,664, 5,547 and 15,532 RSUs in three separate awards, as shown by post-transaction balances for each derivative position. Each award is tied to QuidelOrtho common stock on a one-for-one basis when delivered.
What does it mean that the QuidelOrtho (QDEL) RSUs were received in lieu of cash?
The filing states the RSUs were received instead of cash payments for certain board retainers and service-related fees under a deferred compensation program for non-employee directors, converting what would have been cash compensation into stock-based awards.
When will the QuidelOrtho (QDEL) RSUs be delivered to Mary Lake Polan?
The filing explains that release of vested restricted stock units will occur according to her elected deferral schedule under the deferred compensation program, meaning delivery timing follows her prior elections rather than occurring immediately at vesting.
How many QuidelOrtho (QDEL) RSUs vest on each of the scheduled dates?
According to the footnote, 1,386 RSUs vested on June 25, 2026. Additional tranches of 1,387 RSUs each will vest on September 25, 2026, December 25, 2026, and March 25, 2027, providing a staggered vesting schedule for part of her awards.